DE60326581D1 - Markierte peptide mit einer affinität für ein phospholipid und deren verwendungen - Google Patents

Markierte peptide mit einer affinität für ein phospholipid und deren verwendungen

Info

Publication number
DE60326581D1
DE60326581D1 DE60326581T DE60326581T DE60326581D1 DE 60326581 D1 DE60326581 D1 DE 60326581D1 DE 60326581 T DE60326581 T DE 60326581T DE 60326581 T DE60326581 T DE 60326581T DE 60326581 D1 DE60326581 D1 DE 60326581D1
Authority
DE
Germany
Prior art keywords
amino acids
gly
arg
cys
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326581T
Other languages
English (en)
Inventor
Alain Sanson
Francoise Ochsenbein
Frederic Dolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Pierre et Marie Curie Paris 6
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Universite Pierre et Marie Curie Paris 6
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA, Universite Pierre et Marie Curie Paris 6 filed Critical Commissariat a lEnergie Atomique CEA
Application granted granted Critical
Publication of DE60326581D1 publication Critical patent/DE60326581D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE60326581T 2002-07-01 2003-06-30 Markierte peptide mit einer affinität für ein phospholipid und deren verwendungen Expired - Lifetime DE60326581D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0208204A FR2841558B1 (fr) 2002-07-01 2002-07-01 Peptides marques ayant une affinite pour un phospholipide et utilisations
PCT/FR2003/002027 WO2004003016A2 (fr) 2002-07-01 2003-06-30 Peptides marques ayant une affinite pour un phospholipide et utilisations

Publications (1)

Publication Number Publication Date
DE60326581D1 true DE60326581D1 (de) 2009-04-23

Family

ID=29725045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326581T Expired - Lifetime DE60326581D1 (de) 2002-07-01 2003-06-30 Markierte peptide mit einer affinität für ein phospholipid und deren verwendungen

Country Status (9)

Country Link
US (1) US7919455B2 (de)
EP (1) EP1517919B9 (de)
JP (1) JP4667864B2 (de)
AT (1) ATE425182T1 (de)
AU (1) AU2003259311A1 (de)
CA (1) CA2491344A1 (de)
DE (1) DE60326581D1 (de)
FR (1) FR2841558B1 (de)
WO (1) WO2004003016A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7993626B2 (en) * 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
FR2841554B1 (fr) * 2002-07-01 2008-01-18 Commissariat Energie Atomique Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
FR2856069A1 (fr) * 2003-06-10 2004-12-17 Bionexis Molecules de ciblage et de liberation de composes therapeutiques et leur utilisation
CA2675202C (en) * 2007-01-11 2014-09-16 Immunomedics, Inc. Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
US8889100B2 (en) 2007-01-11 2014-11-18 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US8545809B2 (en) 2007-01-11 2013-10-01 Immunomedics, Inc. Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
JP5013378B2 (ja) * 2007-02-05 2012-08-29 国立大学法人大阪大学 新規ヘキサトリエン−β−カルボニル化合物
JP5250849B2 (ja) * 2007-03-05 2013-07-31 株式会社医学生物学研究所 多価結合手を有し代謝安定性が向上した脳移行性ポリペプチド
JP5847003B2 (ja) * 2012-04-09 2016-01-20 浜松ホトニクス株式会社 １８ｆ標識化化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US4735792A (en) * 1987-04-28 1988-04-05 The United States Of America As Represented By The United States Department Of Energy Radioiodinated maleimides and use as agents for radiolabeling antibodies
EP0538459A4 (en) * 1991-05-09 1993-06-16 The Board Of Regents Of The University Of Washington Phospholipid-targeted thrombolytic agents
ATE353864T1 (de) * 1997-09-03 2007-03-15 Immunomedics Inc Fluorierung von proteinen und peptiden für positronemissionstomographie
FR2784106B1 (fr) * 1998-10-02 2002-04-19 Commissariat Energie Atomique Structure chimique ayant une affinite pour un phospholipide, et compose de marquage, trousse de diagnostic, et medicament comprenant cette structure

Also Published As

Publication number Publication date
AU2003259311A8 (en) 2004-01-19
CA2491344A1 (fr) 2004-01-08
WO2004003016A3 (fr) 2004-04-08
WO2004003016A2 (fr) 2004-01-08
AU2003259311A1 (en) 2004-01-19
US7919455B2 (en) 2011-04-05
US20060233706A1 (en) 2006-10-19
JP2006510577A (ja) 2006-03-30
EP1517919A2 (de) 2005-03-30
EP1517919B1 (de) 2009-03-11
JP4667864B2 (ja) 2011-04-13
ATE425182T1 (de) 2009-03-15
FR2841558A1 (fr) 2004-01-02
FR2841558B1 (fr) 2004-08-13
EP1517919B9 (de) 2009-09-16

Similar Documents

Publication Publication Date Title
Atoda et al. The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E
MY147327A (en) Somatostatin peptides
JP2003522200A5 (de)
DE3486154D1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung.
HK1044898A1 (zh) 載脂蛋白a-i激動劑及其治療脂血異常症的用途
MX9606536A (es) Proteinas n-terminalmente extendidas expresadas en levaduras.
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DE60326581D1 (de) Markierte peptide mit einer affinität für ein phospholipid und deren verwendungen
ES2123635T3 (es) Nuevo inhibidor de la proteasa humana de tipo kunitz y sus variantes.
HK1084403A1 (en) Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
DE60326726D1 (de) Peptide mit affinität für ein phospholipid und deren verwendung
Tokunaga et al. The NH2‐terminal residues of rat liver proteasome (multicatalytic proteinase complex) subunits, C2, C3 and C8, are Nα‐acetylated
Martin et al. Sequence homologies between p36, the substrate of pp60src tyrosine kinase and a 67 kDa protein isolated from bovine aorta
WO1999002708A8 (en) Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein
NO963851D0 (no) Biotinderivater
AU7196596A (en) Peptides and antibodies for treatment of rheumatoid arthritis
Seyer et al. Covalent structure of collagen: Amino acid sequence of three cyanogen bromide-derived peptides from human α1 (V) collagen chain
ATE129744T1 (de) Rekombinantes c-terminal alpha amidatierungsenzym von menschlischem thyroidursprung.
WO1999057262A3 (de) An metallionen bindendes peptid
GRANDIER-VAZEILLE et al. Evaluation of Commercial RP-HPLC Columns for the Separation of Peptides from Porcine Cardiac Myosin Light Chain L27
Abatangelo et al. Chemical characterization of α-elastin components
CO4340568A1 (es) Familia de peptidos con 51 aminoacidos en longitud, secuen- cias de definicion, la planta transgenica comprendida, el vector de expresion recombinante y el metodo para su pro- duccion.
Yoshida et al. Revision of the Amino Acid Sequence of Ribonuclease F1
Tachibana et al. Isolation of dynorphin-like peptide from gut extract

Legal Events

Date Code Title Description
8364 No opposition during term of opposition